Beaufort Securities view on Advanced Oncotherapy (AVO)

Beaufort Securities view on Advanced Oncotherapy (AVO). It always comes as a surprise when the market reacts violently to some news item whose impact was considered already to be priced-in. Yesterday’s announcement told shareholders nothing new. Back in November, AVO detailed the fact that Sinophi was no longer to proceed with the installation of LIGHT […]

Daily Telegraph – Shares in Advanced Oncotherapy jump amid chatter of Chinese contract win

By Tara Cunningham, Business Reporter, Daily Telegraph: As global equity markets faltered last week, Advanced Oncotherapy bucked the trend amid chatter of a contract win in China. Speculation Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, secured a second contract in China drove the share price higher last week. While global […]

Advanced Oncotherapy (AVO) – Sinophi agreement with Jilin University

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, confirms that its partner for the Chinese market, Sinophi Healthcare Limited, has recently signed a Framework Agreement with China-Japan Union Hospital of Jilin University in relation to a proton therapy centre. Advanced Oncotherapy confirms that this Framework Agreement does not as yet […]